Sunitinib

Generic name: Pronounced as (soo ni' ti nib)
Brand names
  • Sutent®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 02/15/2022

Sunitinib may cause serious or life-threatening damage to the liver. Tell your doctor if you have or have ever had liver disease or problems with your liver. If you experience any of the following symptoms, call your doctor immediately: itching, yellow eyes and skin, dark urine, or pain or discomfort in the right upper stomach area. Your doctor may have to decrease your dose of sunitinib or permanently or temporarily stop your treatment.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain blood tests before and during your treatment to be sure that it is safe for you to take sunitinib and to check your body's response to the medication.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with sunitinib and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Talk to your doctor about the risks of taking sunitinib.

Sunitinib is used to treat gastrointestinal stromal tumors (GIST; a type of tumor that grows in the stomach, intestine (bowel), or esophagus (tube that connects the throat with the stomach) in people with tumors that were not treated successfully with imatinib (Gleevec) or people who cannot take imatinib. Sunitinib is also used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys). Sunitinib is also used to help prevent the return of RCC in people who have RCC that has not spread and have had a kidney removed. Sunitinib is also used to treat pancreatic neuroendocrine tumors (pNET, a type of tumor that begins in certain cells of the pancreas) in people with tumors that have worsened and cannot be treated with surgery. Sunitinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells and may help shrink tumors.

Sunitinib comes as a capsule to take by mouth with or without food. For the treatment of gastrointestinal stromal tumors (GIST), or for the treatment renal cell carcinoma (RCC), sunitinib is usually taken once a day for 4 weeks (28 days) followed by a 2-week break before beginning the next dosing cycle and repeated every 6 weeks for as long as your doctor recommends. For the prevention of RCC, sunitinib is usually taken once a day for 4 weeks (28 days) followed by a 2-week break before beginning the next dosing cycle and repeating every 6 weeks for 9 cycles. For the treatment of pancreatic neuroendocrine tumors (pNET), sunitinib is usually taken once daily. Take sunitinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take sunitinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the capsules whole; do not split, chew, or crush them. Do not open the capsules.

You may need to take one or more capsules at a time depending on your dose of sunitinib.

Your doctor may decrease your dose or temporarily or permanently stop yourtreatment if you experience certain side effects. This depends on how well the medication works for you and the side effects you experience. Talk to your doctor about how you are feeling during your treatment with sunitinib.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking sunitinib,

  • tell your doctor and pharmacist if you are allergic to sunitinib, any ingredients of sunitinib capsules, or any other medications. Ask your pharmacist or check the manufacturer's patient information sheet (Medication Guide) for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: certain antibiotics such as clarithromycin (Biaxin, in Prevpac), rifampin (Rifadin, Rimactane, in Rifamate, in Rifater), rifabutin (Mycobutin), rifapentine (Priftin), and telithromycin (Ketek); certain antifungals such as itraconazole (Onmel, Sporanox), ketoconazole, and voriconazole (Vfend); dexamethasone; medications for diabetes; certain medications for human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) including atazanavir (Reyataz, in Evotaz), indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Invirase); nefazodone; certain medications for seizures such as carbamazepine (Carbatrol, Epitol, Equetro, Tegretol, Teril), phenobarbital, and phenytoin (Dilantin, Phenytek). Also tell your doctor if you are taking or have taken alendronate (Binosto, Fosamax), etidronate, ibandronate (Boniva), pamidronate, risedronate (Actonel, Atelvia), or zoledronic acid injection (Reclast, Zometa), Other medications may also interact with sunitinib, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor and pharmacist what herbal products you are taking, especially St. John's wort. Do not take St. John's wort while taking sunitinib.

  • tell your doctor if you have or have ever had a bleeding problem; a blood clot in the lungs; a QT interval prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death); a slow, fast, or irregular heartbeat; a heart attack; heart failure; high blood pressure; seizures; low blood sugar or diabetes; low levels of potassium or magnesium in your blood; problems with your mouth, teeth or gums; or kidney, thyroid, or heart disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or if you plan to father a child. You or your partner should not become pregnant while you are taking sunitinib. If you are female, you will need to have a pregnancy test before you start treatment, and you should use birth control to prevent pregnancy during your sunitinib treatment and for 4 weeks after your final dose. If you are male, you and your partner should use birth control to prevent pregnancy during your treatment with sunitinib and for 7 weeks after your final dose. Talk to your doctor about birth control methods that you can use during your treatment. Sunitinib may decrease fertility in men and women. However, you should not assume that you or your partner cannot become pregnant. If you or your partner become pregnant while taking sunitinib, call your doctor. Sunitinib may harm the fetus.

  • tell your doctor if you are breastfeeding. You should not breastfeed during your treatment with sunitinib and for 4 weeks after your final dose.

  • if you are having surgery tell the doctor or dentist that you are taking sunitinib. Your doctor will probably tell you to stop taking sunitinib at least 3 weeks before your scheduled surgery because it can affect wound healing. Your doctor will tell you when to start taking sunitinib again after your surgery.

  • you should know that sunitinib may cause your skin to turn yellow and your hair to lighten and lose color. This is probably caused by the yellow color of the medication and is not harmful or painful.

  • you should know that sunitinib may cause high blood pressure. Your blood pressure should be checked regularly while you are taking sunitinib.

  • you should know that sunitinib may cause osteonecrosis of the jaw (ONJ, a serious condition of the jaw bone), especially if you have dental surgery or treatment while you are taking the medication. A dentist should examine your teeth and perform any needed treatments, including cleaning or fixing ill-fitted dentures, before you start to take sunitinib. Be sure to brush your teeth and clean your mouth properly while you are taking sunitinib. Tell your doctor or dentist if you have or have had mouth, teeth, or jaw pain; mouth sores or swelling; numbness or a feeling of heaviness in the jaw; or any loose teeth. Talk to your doctor before having any dental treatments while you are taking this medication.

Do not eat grapefruit or drink grapefruit juice while taking this medication.

If you miss a dose of sunitinib by less than 12 hours, take the missed dose as soon as you remember it and then take the next dose at the scheduled time. However, if you miss a dose by more than 12 hours, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Sunitinib may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • weakness

    • nausea

    • vomiting

    • diarrhea

    • constipation

    • heartburn

    • gas

    • hemorrhoids

    • pain, irritation, or burning sensation of the lips, tongue, mouth or throat

    • dry mouth

    • change in the way things taste

    • loss of appetite

    • weight changes

    • hair loss

    • thin, brittle fingernails or hair

    • slow speech

    • pale or dry skin

    • shaking

    • heavy, irregular, or missed menstrual periods

    • depression

    • difficulty falling asleep or staying asleep

    • dryness, thickness, cracking, or blistering of skin on the palms of the hands and the soles of the feet

    • muscle, joint, back, or limb pain

    • frequent nosebleeds

    • bleeding from your gums

    • unusual discomfort in cold temperatures

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS sections, call your doctor immediately:

    • unusual bruising or bleeding

    • bloody or black and tarry stools

    • blood in the urine

    • vomit that is bright red or looks like coffee grounds

    • coughing up blood

    • stomach pain, swelling, or tenderness

    • headache

    • fever

    • swelling, tenderness, warmth, or redness of a leg

    • swelling of the feet or ankles

    • rapid, irregular, or pounding heartbeat

    • dizziness or fainting

    • decreased alertness or concentration

    • confusion

    • depression

    • nervousness

    • seizures

    • vision changes

    • chest pain or pressure

    • extreme tiredness

    • shortness of breath

    • pain with deep breathing

    • unexplained weight gain

    • decreased urination

    • cloudy urine

    • swelling of the eyes, face, lips, tongue, or throat

    • rash

    • hives

    • blistering or peeling skin or inside of mouth

    • difficulty swallowing or breathing

    • hoarseness

  • Sunitinib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests such as electrocardiograms (EKG, test that records the electrical activity of the heart), echocardiograms (test that uses sound waves to measure your heart's ability to pump blood), and urine tests before and during your treatment with sunitinib to be sure it is safe for you to take sunitinib, and to check your body's response to the medication.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The therapeutic efficacy of Sunitinib can be increased when used in combination with Moxifloxacin.
Repaglinide Repaglinide The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Sunitinib.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sunitinib.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Sunitinib is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Sunitinib can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Sunitinib can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Sunitinib.
Dolasetron Dolasetron The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Dolasetron.
Alendronate Alendronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Alendronic acid.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Sunitinib.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Anagrelide.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Sunitinib.
Clopidogrel Clopidogrel The metabolism of Sunitinib can be decreased when combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Sunitinib can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Sunitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Sunitinib.
Methylergonovine Methylergonovine The metabolism of Sunitinib can be decreased when combined with Methylergometrine.
Miglitol Miglitol The risk or severity of hypoglycemia can be increased when Miglitol is combined with Sunitinib.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Sunitinib.
Olsalazine Olsalazine Olsalazine may increase the hypoglycemic activities of Sunitinib.
Penbutolol Penbutolol The therapeutic efficacy of Acebutolol can be increased when used in combination with Sunitinib.
Prednisone Prednisone The risk or severity of hyperglycemia can be increased when Prednisone is combined with Sunitinib.
Reserpine Reserpine The metabolism of Sunitinib can be increased when combined with Reserpine.
Sumatriptan Sumatriptan Sunitinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Sunitinib.
Tiludronate Tiludronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Etidronic acid.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Sunitinib.
Triamcinolone Triamcinolone The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Sunitinib.
Doxycycline Injection Doxycycline Injection The metabolism of Sunitinib can be decreased when combined with Doxycycline.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Sunitinib.
Fluconazole Injection Fluconazole Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Sunitinib.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Sunitinib.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sunitinib.
Levofloxacin Injection Levofloxacin Injection The therapeutic efficacy of Sunitinib can be increased when used in combination with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be increased when combined with Sunitinib.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Sunitinib.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Sunitinib.
Metronidazole Injection Metronidazole Injection The metabolism of Sunitinib can be decreased when combined with Metronidazole.
Pamidronate Injection Pamidronate Injection The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Pamidronic acid.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Sunitinib.
Altretamine Altretamine Amphetamine may increase the hypoglycemic activities of Sunitinib.
Cyclosporine Cyclosporine Sunitinib may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Ondansetron.
Granisetron Granisetron The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Granisetron.
Torsemide Torsemide The therapeutic efficacy of Sunitinib can be increased when used in combination with Torasemide.
Olanzapine Olanzapine The therapeutic efficacy of Sunitinib can be decreased when used in combination with Olanzapine.
Alosetron Alosetron The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Alosetron.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Sunitinib.
Hydroxychloroquine Hydroxychloroquine The therapeutic efficacy of Hydroxychloroquine can be increased when used in combination with Sunitinib.
Orlistat Orlistat The metabolism of Sunitinib can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Sunitinib can be increased when combined with Oxcarbazepine.
Risedronate Risedronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Risedronic acid.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Sunitinib.
Zaleplon Zaleplon The metabolism of Sunitinib can be decreased when combined with Zaleplon.
Anakinra Anakinra The metabolism of Sunitinib can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Desloratadine.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Sunitinib.
Trimipramine Trimipramine Trimipramine may decrease the hypoglycemic activities of Sunitinib.
Etanercept Injection Etanercept Injection The metabolism of Sunitinib can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Sunitinib can be increased when combined with Modafinil.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Sunitinib.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Sunitinib.
Dutasteride Dutasteride The metabolism of Sunitinib can be decreased when combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Sunitinib can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Sunitinib.
Eplerenone Eplerenone The metabolism of Sunitinib can be decreased when combined with Eplerenone.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Escitalopram.
Zonisamide Zonisamide The metabolism of Sunitinib can be decreased when combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Sunitinib can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Sunitinib.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Sunitinib.
Ezetimibe Ezetimibe Sunitinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Glatiramer.
Teriparatide Injection Teriparatide Injection The therapeutic efficacy of Teriparatide can be decreased when used in combination with Sunitinib.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Sunitinib.
Mefloquine Mefloquine The metabolism of Sunitinib can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Sunitinib can be decreased when combined with Rosuvastatin.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Sunitinib.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Sunitinib.
Aprepitant Aprepitant The metabolism of Sunitinib can be decreased when combined with Aprepitant.
Tegaserod Tegaserod Sunitinib may decrease the excretion rate of Tegaserod which could result in a higher serum level.
Tadalafil Tadalafil The metabolism of Sunitinib can be decreased when combined with Tadalafil.
Fosamprenavir Fosamprenavir The therapeutic efficacy of Sunitinib can be decreased when used in combination with Fosamprenavir.
Gemifloxacin Gemifloxacin The therapeutic efficacy of Sunitinib can be increased when used in combination with Gemifloxacin.
Progesterone Progesterone The metabolism of Sunitinib can be increased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The metabolism of Sunitinib can be decreased when combined with Apomorphine.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sunitinib.
Infliximab Injection Infliximab Injection The metabolism of Sunitinib can be increased when combined with Infliximab.
Oxandrolone Oxandrolone Oxandrolone may increase the hypoglycemic activities of Sunitinib.
Protriptyline Protriptyline Protriptyline may decrease the hypoglycemic activities of Sunitinib.
Rifaximin Rifaximin The metabolism of Sunitinib can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Sunitinib.
Norethindrone Norethindrone The metabolism of Sunitinib can be decreased when combined with Norethisterone.
Bosentan Bosentan The metabolism of Sunitinib can be increased when combined with Bosentan.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Sunitinib.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Sunitinib.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Insulin aspart.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Solifenacin.
Voriconazole Voriconazole The metabolism of Sunitinib can be decreased when combined with Voriconazole.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Zoledronic acid.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the hypoglycemic activities of Sunitinib.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sunitinib.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sunitinib.
Pramlintide Injection Pramlintide Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Pramlintide.
Exenatide Injection Exenatide Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Exenatide.
Ibandronate Ibandronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Ibandronate.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypoglycemic activities of Sunitinib.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Sunitinib.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Sunitinib.
Deferasirox Deferasirox The metabolism of Sunitinib can be increased when combined with Deferasirox.
Tipranavir Tipranavir The metabolism of Sunitinib can be decreased when combined with Tipranavir.
Felbamate Felbamate The metabolism of Sunitinib can be increased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Insulin detemir.
Ranolazine Ranolazine The metabolism of Ranolazine can be decreased when combined with Sunitinib.
Abatacept Injection Abatacept Injection The metabolism of Sunitinib can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the hypoglycemic activities of Sunitinib.
Imatinib Imatinib The metabolism of Sunitinib can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Sunitinib.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Bevacizumab.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Sunitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Sunitinib.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Sunitinib.
Bortezomib Bortezomib The metabolism of Sunitinib can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Sunitinib.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Sunitinib.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Sunitinib.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Sunitinib.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Sunitinib.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Insulin glulisine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Sunitinib.
Posaconazole Posaconazole The metabolism of Sunitinib can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Sunitinib.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Sunitinib.
Bismuth Subsalicylate Bismuth Subsalicylate Bismuth subsalicylate may increase the hypoglycemic activities of Sunitinib.
Darunavir Darunavir The serum concentration of Sunitinib can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Sunitinib.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Dimenhydrinate.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Sunitinib.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Sunitinib is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Sunitinib can be decreased when combined with Sorafenib.
Lapatinib Lapatinib The metabolism of Sunitinib can be decreased when combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Sunitinib.
Armodafinil Armodafinil The metabolism of Sunitinib can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Sunitinib.
Ivermectin Ivermectin The metabolism of Ivermectin can be increased when combined with Sunitinib.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Sunitinib.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Sunitinib.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Sunitinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Sunitinib can be increased when combined with Bexarotene.
Budesonide Budesonide The risk or severity of hyperglycemia can be increased when Sunitinib is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Sunitinib can be decreased when combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Decitabine is combined with Sunitinib.
Etravirine Etravirine The metabolism of Sunitinib can be increased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Sunitinib.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Sunitinib can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Desvenlafaxine can be decreased when combined with Sunitinib.
Nebivolol Nebivolol The therapeutic efficacy of Nebivolol can be increased when used in combination with Sunitinib.
Tretinoin Tretinoin The metabolism of Sunitinib can be decreased when combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Bendamustine.
Pilocarpine Pilocarpine The metabolism of Sunitinib can be decreased when combined with Pilocarpine.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Sunitinib can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Sunitinib.
Irinotecan Injection Irinotecan Injection The metabolism of Sunitinib can be decreased when combined with Irinotecan.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Estramustine is combined with Sunitinib.
Praziquantel Praziquantel The metabolism of Sunitinib can be decreased when combined with Praziquantel.
Mitotane Mitotane The metabolism of Sunitinib can be increased when combined with Mitotane.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Sunitinib.
Rufinamide Rufinamide The metabolism of Rufinamide can be increased when combined with Sunitinib.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Sunitinib.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Sunitinib.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Sunitinib.
Milnacipran Milnacipran The metabolism of Milnacipran can be decreased when combined with Sunitinib.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Degarelix.
Betaxolol Betaxolol The therapeutic efficacy of Betaxolol can be increased when used in combination with Sunitinib.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Sunitinib.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Sunitinib.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Sunitinib.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Sunitinib.
Dronedarone Dronedarone The serum concentration of Dronedarone can be increased when it is combined with Sunitinib.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Palonosetron.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Sunitinib.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Sunitinib.
Topotecan Topotecan The metabolism of Topotecan can be increased when combined with Sunitinib.
Golimumab Injection Golimumab Injection The metabolism of Sunitinib can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Sunitinib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Asenapine.
Pitavastatin Pitavastatin Sunitinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Sunitinib.
Levonorgestrel Levonorgestrel The metabolism of Sunitinib can be decreased when combined with Levonorgestrel.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Sunitinib.
Liraglutide Injection Liraglutide Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Sunitinib can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Sunitinib may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Sunitinib.
Lurasidone Lurasidone The therapeutic efficacy of Sunitinib can be decreased when used in combination with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Sunitinib.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Sunitinib can be decreased when combined with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Sunitinib.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Sunitinib.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Sunitinib.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Sunitinib.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Sunitinib.
Rilpivirine Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Sunitinib.
Telaprevir Telaprevir The metabolism of Glecaprevir can be decreased when combined with Sunitinib.
Potassium Iodide Potassium Iodide The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Sunitinib.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Sunitinib can be increased when combined with Cyclophosphamide.
Triptorelin Injection Triptorelin Injection The therapeutic efficacy of Sunitinib can be decreased when used in combination with Triptorelin.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Sunitinib.
Ticagrelor Ticagrelor The metabolism of Sunitinib can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Sunitinib.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Sunitinib.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Sunitinib.
Clobazam Clobazam The metabolism of Sunitinib can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Vemurafenib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Sunitinib.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Sunitinib.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Sunitinib.
Crizotinib Crizotinib The metabolism of Sunitinib can be decreased when combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Melphalan is combined with Sunitinib.
Cabergoline Cabergoline The metabolism of Sunitinib can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Sunitinib can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Sunitinib.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Eculizumab is combined with Sunitinib.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Carfilzomib.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Sunitinib.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mirabegron.
Regorafenib Regorafenib The metabolism of Sunitinib can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Sunitinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of hyperglycemia can be increased when Sunitinib is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Sunitinib is combined with Teriflunomide.
Lorcaserin Lorcaserin The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Mecasermin.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bedaquiline.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Sunitinib.
Alogliptin Alogliptin The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Alogliptin.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Sunitinib is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Sunitinib.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Sunitinib.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Sunitinib.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Sunitinib.
Canagliflozin Canagliflozin Canagliflozin may increase the hypoglycemic activities of Sunitinib.
Methazolamide Methazolamide The therapeutic efficacy of Sunitinib can be increased when used in combination with Methazolamide.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be increased when combined with Sunitinib.
Trametinib Trametinib The metabolism of Sunitinib can be increased when combined with Trametinib.
Dolutegravir Dolutegravir Sunitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Afatinib Afatinib Sunitinib may decrease the excretion rate of Afatinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Sunitinib.
Vortioxetine Vortioxetine The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Vortioxetine.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Sunitinib.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Sunitinib.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Sunitinib.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Simeprevir can be decreased when combined with Sunitinib.
Sofosbuvir Sofosbuvir Sunitinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the hypoglycemic activities of Sunitinib.
Apremilast Apremilast The metabolism of Sunitinib can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Sunitinib.
Siltuximab Injection Siltuximab Injection The metabolism of Sunitinib can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Albiglutide.
Eslicarbazepine Eslicarbazepine The metabolism of Sunitinib can be increased when combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Sunitinib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Sunitinib.
Oritavancin Injection Oritavancin Injection The metabolism of Sunitinib can be increased when combined with Oritavancin.
Empagliflozin Empagliflozin The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Empagliflozin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Sunitinib.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Sunitinib.
Dulaglutide Injection Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Dulaglutide.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Sunitinib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Blinatumomab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Sunitinib.
Riociguat Riociguat Sunitinib may decrease the excretion rate of Riociguat which could result in a higher serum level.
Lanreotide Injection Lanreotide Injection The metabolism of Sunitinib can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Sunitinib is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Sunitinib.
Secukinumab Injection Secukinumab Injection The metabolism of Sunitinib can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Sunitinib can be decreased when combined with Risperidone.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Sunitinib.
Insulin Human Inhalation Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sunitinib.
Lenvatinib Lenvatinib The metabolism of Lenvatinib can be increased when combined with Sunitinib.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Sunitinib.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Haloperidol.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ivabradine.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Sunitinib can be increased when combined with Isavuconazonium.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Sunitinib.
Prednisolone Prednisolone The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Sunitinib.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Sunitinib.
Brexpiprazole Brexpiprazole The therapeutic efficacy of Sunitinib can be decreased when used in combination with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ziprasidone.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Sunitinib.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Sunitinib.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Sunitinib.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Sunitinib.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Sunitinib.
Rifapentine Rifapentine The metabolism of Sunitinib can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Sunitinib can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Sunitinib can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sunitinib.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Ixekizumab.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Sunitinib.
Cobicistat Cobicistat The metabolism of Sunitinib can be decreased when combined with Cobicistat.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Sunitinib.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Sunitinib can be increased when used in combination with Furosemide.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Sunitinib.
Lixisenatide Injection Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Lixisenatide.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Sunitinib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Brodalumab.
Parathyroid Hormone Injection Parathyroid Hormone Injection The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Sunitinib.
Brigatinib Brigatinib The metabolism of Brigatinib can be increased when combined with Sunitinib.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may decrease the hypoglycemic activities of Sunitinib.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Sunitinib.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Sunitinib.
Deflazacort Deflazacort The risk or severity of hyperglycemia can be increased when Sunitinib is combined with Deflazacort.
Safinamide Safinamide The metabolism of Sunitinib can be decreased when combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Ocrelizumab.
Sarilumab Injection Sarilumab Injection The metabolism of Sarilumab can be increased when combined with Sunitinib.
Midostaurin Midostaurin The metabolism of Sunitinib can be increased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Sunitinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Guselkumab.
Abaloparatide Injection Abaloparatide Injection The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Sunitinib.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Sunitinib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Sunitinib.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Sunitinib.
Delafloxacin Delafloxacin The therapeutic efficacy of Sunitinib can be increased when used in combination with Delafloxacin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Sunitinib.
Acalabrutinib Acalabrutinib The metabolism of Sunitinib can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sunitinib.
Letermovir Letermovir The metabolism of Sunitinib can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Sunitinib can be increased when used in combination with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Sunitinib can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The metabolism of Sunitinib can be increased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Sunitinib.
Fostamatinib Fostamatinib The metabolism of Sunitinib can be decreased when combined with Fostamatinib.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Sunitinib.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lofexidine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Sunitinib.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Encorafenib.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Sunitinib.
Lusutrombopag Lusutrombopag Sunitinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Sunitinib.
Cannabidiol Cannabidiol The metabolism of Sunitinib can be decreased when combined with Cannabidiol.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Sunitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Sunitinib.
Stiripentol Stiripentol The metabolism of Sunitinib can be decreased when combined with Stiripentol.
Talazoparib Talazoparib Sunitinib may decrease the excretion rate of Talazoparib which could result in a higher serum level.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Sunitinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Sunitinib.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Sunitinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Sunitinib.
Rifamycin Rifamycin The metabolism of Sunitinib can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Sunitinib.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Sunitinib can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Sunitinib.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Sunitinib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Sunitinib is combined with Risankizumab.
Alpelisib Alpelisib The serum concentration of Alpelisib can be increased when it is combined with Sunitinib.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Sunitinib.
Darolutamide Darolutamide Sunitinib may decrease the excretion rate of Darolutamide which could result in a higher serum level.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Sunitinib.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Entrectinib.
Pexidartinib Pexidartinib Sunitinib may increase the hepatotoxic activities of Pexidartinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Sunitinib.
Pitolisant Pitolisant The serum concentration of Sunitinib can be decreased when it is combined with Pitolisant.
Lefamulin Lefamulin Sunitinib may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Sunitinib can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Sunitinib.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Sunitinib.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Sunitinib.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Sunitinib.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Sunitinib.
Cenobamate Cenobamate The serum concentration of Sunitinib can be decreased when it is combined with Cenobamate.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The therapeutic efficacy of Sunitinib can be decreased when used in combination with Teprotumumab.
Ozanimod Ozanimod Sunitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Sunitinib.
Rimegepant Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Sunitinib.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Sunitinib.
Ripretinib Ripretinib Sunitinib may decrease the excretion rate of Ripretinib which could result in a higher serum level.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Sunitinib.
Fostemsavir Fostemsavir Sunitinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Octreotide Octreotide The therapeutic efficacy of Sunitinib can be decreased when used in combination with Octreotide.
Pralsetinib Pralsetinib The metabolism of Pralsetinib can be increased when combined with Sunitinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Sunitinib can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Sunitinib can be decreased when combined with Drospirenone.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Sunitinib can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Sunitinib.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Sunitinib.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Sunitinib.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Sunitinib.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Sunitinib.
Phenobarbital Phenobarbital The metabolism of Sunitinib can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The metabolism of Sunitinib can be decreased when combined with Methotrexate.
Primidone Primidone The metabolism of Sunitinib can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Methsuximide.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be increased when combined with Sunitinib.
Diazepam Diazepam The metabolism of Sunitinib can be decreased when combined with Diazepam.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Sunitinib.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Sunitinib.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Sunitinib.
Bromocriptine Bromocriptine The metabolism of Bromocriptine can be decreased when combined with Sunitinib.
Tranylcypromine Tranylcypromine The metabolism of Sunitinib can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Sunitinib can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Sunitinib.
Tetracycline Tetracycline The metabolism of Sunitinib can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Sunitinib.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Sunitinib.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Thioridazine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Sunitinib.
Dapsone Dapsone The metabolism of Sunitinib can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Sunitinib can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Sunitinib can be increased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Sunitinib can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sunitinib.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Sunitinib.
Orphenadrine Orphenadrine The metabolism of Sunitinib can be decreased when combined with Orphenadrine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Azathioprine is combined with Sunitinib.
Phentermine Phentermine The therapeutic efficacy of Sunitinib can be increased when used in combination with Phentermine.
Amoxapine Amoxapine Amoxapine may decrease the hypoglycemic activities of Sunitinib.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Sunitinib.
Hydrocortisone Hydrocortisone The risk or severity of hyperglycemia can be increased when Sunitinib is combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Lomustine is combined with Sunitinib.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Sunitinib.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Sunitinib.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Sunitinib.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Sunitinib.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Sunitinib.
Clonidine Clonidine The metabolism of Sunitinib can be decreased when combined with Clonidine.
Prazosin Prazosin Sunitinib may decrease the excretion rate of Prazosin which could result in a higher serum level.
Hydralazine Hydralazine The metabolism of Sunitinib can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Sunitinib can be decreased when combined with Cimetidine.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Sunitinib.
Loperamide Loperamide The metabolism of Sunitinib can be decreased when combined with Loperamide.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Promethazine is combined with Sunitinib.
Daunorubicin Daunorubicin The metabolism of Sunitinib can be decreased when combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Sunitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Sunitinib can be increased when combined with Griseofulvin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Sunitinib.
Chloroquine Chloroquine The metabolism of Sunitinib can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Quinine can be increased when combined with Sunitinib.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Sunitinib.
Calcitriol Calcitriol The metabolism of Sunitinib can be increased when combined with Calcitriol.
Sulfinpyrazone Sulfinpyrazone The metabolism of Sunitinib can be increased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Sunitinib can be decreased when used in combination with Chlorothiazide.
Chlorthalidone Chlorthalidone The therapeutic efficacy of Sunitinib can be decreased when used in combination with Chlorthalidone.
Metolazone Metolazone The therapeutic efficacy of Sunitinib can be decreased when used in combination with Metolazone.
Clindamycin Injection Clindamycin Injection The metabolism of Sunitinib can be decreased when combined with Clindamycin.
Secobarbital Secobarbital The metabolism of Sunitinib can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Sunitinib can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Sunitinib can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Sunitinib can be decreased when combined with Imipramine.
Probenecid Probenecid The metabolism of Sunitinib can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Sunitinib.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Procainamide.
Isoniazid Isoniazid The metabolism of Sunitinib can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Sunitinib can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Disopyramide.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Sunitinib.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Sunitinib.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Sunitinib.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Sunitinib.
Liothyronine Liothyronine The therapeutic efficacy of Sunitinib can be decreased when used in combination with Liothyronine.
Methimazole Methimazole The therapeutic efficacy of Sunitinib can be decreased when used in combination with Methimazole.
Propylthiouracil Propylthiouracil The therapeutic efficacy of Sunitinib can be decreased when used in combination with Propylthiouracil.
Chlorpropamide Chlorpropamide The risk or severity of hypoglycemia can be increased when Chlorpropamide is combined with Sunitinib.
Tolbutamide Tolbutamide The risk or severity of hypoglycemia can be increased when Tolbutamide is combined with Sunitinib.
Tolazamide Tolazamide The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Sunitinib.
Dextromethorphan Dextromethorphan The metabolism of Sunitinib can be decreased when combined with Dextromethorphan.
Niacin Niacin The metabolism of Sunitinib can be decreased when combined with Niacin.
Baclofen Baclofen The therapeutic efficacy of Sunitinib can be decreased when used in combination with Baclofen.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Sunitinib.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Sunitinib.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Sunitinib.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Sunitinib.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Sunitinib can be decreased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Sunitinib can be decreased when used in combination with Hydrochlorothiazide.
Folic Acid Folic Acid Sunitinib may decrease the excretion rate of Folic acid which could result in a higher serum level.
Danazol Danazol The metabolism of Sunitinib can be decreased when combined with Danazol.
Disulfiram Disulfiram The metabolism of Sunitinib can be decreased when combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The therapeutic efficacy of Sunitinib can be increased when used in combination with Propranolol.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Sunitinib can be decreased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Sunitinib can be decreased when combined with Nortriptyline.
Amphotericin B Injection Amphotericin B Injection The metabolism of Sunitinib can be decreased when combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Sunitinib.
Nadolol Nadolol The therapeutic efficacy of Nadolol can be increased when used in combination with Sunitinib.
Allopurinol Allopurinol Sunitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sunitinib.
Fluoxymesterone Fluoxymesterone Fluoxymesterone may increase the hypoglycemic activities of Sunitinib.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Sunitinib.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Sunitinib.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Sunitinib.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Sunitinib.
Acetazolamide Acetazolamide The metabolism of Sunitinib can be decreased when combined with Acetazolamide.
Calcitonin Salmon Injection Calcitonin Salmon Injection The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Sunitinib.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Sunitinib.
Ketoconazole Ketoconazole The metabolism of Sunitinib can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Sunitinib.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Sunitinib.
Vinblastine Vinblastine The metabolism of Sunitinib can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid The therapeutic efficacy of Sunitinib can be decreased when used in combination with Etacrynic acid.
Metoprolol Metoprolol The therapeutic efficacy of Metoprolol can be increased when used in combination with Sunitinib.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Sunitinib.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Thiothixene.
Aspirin Aspirin The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Sunitinib.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Sunitinib.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Sunitinib.
Triazolam Triazolam The metabolism of Sunitinib can be decreased when combined with Triazolam.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sunitinib.
Diltiazem Diltiazem The metabolism of Sunitinib can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Sunitinib can be increased when combined with Nifedipine.
Timolol Timolol The therapeutic efficacy of Timolol can be increased when used in combination with Sunitinib.
Verapamil Verapamil The metabolism of Sunitinib can be decreased when combined with Verapamil.
Atenolol Atenolol The therapeutic efficacy of Sunitinib can be increased when used in combination with Atenolol.
Pindolol Pindolol The therapeutic efficacy of Sunitinib can be increased when used in combination with Pindolol.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Sunitinib.
Diflunisal Diflunisal Diflunisal may increase the hypoglycemic activities of Sunitinib.
Bumetanide Bumetanide The therapeutic efficacy of Sunitinib can be increased when used in combination with Bumetanide.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Sunitinib.
Etoposide Etoposide The metabolism of Sunitinib can be increased when combined with Etoposide.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Sunitinib.
Glipizide Glipizide The risk or severity of hypoglycemia can be increased when Glipizide is combined with Sunitinib.
Indapamide Indapamide The therapeutic efficacy of Sunitinib can be decreased when used in combination with Indapamide.
Dicloxacillin Dicloxacillin The metabolism of Sunitinib can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Sunitinib can be increased when combined with Nafcillin.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Sunitinib.
Labetalol Labetalol The therapeutic efficacy of Sunitinib can be increased when used in combination with Labetalol.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Leuprolide.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Sunitinib.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Sunitinib.
Buspirone Buspirone The metabolism of Sunitinib can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Sunitinib.
Ciprofloxacin Ciprofloxacin The metabolism of Sunitinib can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may increase the hypoglycemic activities of Sunitinib.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Sunitinib.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Sunitinib.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Sunitinib.
Clozapine Clozapine The metabolism of Sunitinib can be increased when combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Idarubicin is combined with Sunitinib.
Ofloxacin Ofloxacin The therapeutic efficacy of Sunitinib can be increased when used in combination with Ofloxacin.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Fludarabine is combined with Sunitinib.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Sunitinib.
Clarithromycin Clarithromycin The metabolism of Sunitinib can be decreased when combined with Clarithromycin.
Benazepril Benazepril The risk or severity of hypoglycemia can be increased when Benazepril is combined with Sunitinib.
Felodipine Felodipine The metabolism of Sunitinib can be decreased when combined with Felodipine.
Pravastatin Pravastatin Sunitinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.
Simvastatin Simvastatin The metabolism of Sunitinib can be decreased when combined with Simvastatin.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sunitinib.
Amlodipine Amlodipine The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Sunitinib.
Teniposide Injection Teniposide Injection The metabolism of Sunitinib can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Sunitinib can be decreased when combined with Itraconazole.
Rifabutin Rifabutin The metabolism of Sunitinib can be increased when combined with Rifabutin.
Sotalol Sotalol The risk or severity of hypoglycemia can be increased when Sotalol is combined with Sunitinib.
Bisoprolol Bisoprolol The therapeutic efficacy of Sunitinib can be increased when used in combination with Bisoprolol.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Sunitinib.
Isradipine Isradipine The metabolism of Sunitinib can be decreased when combined with Isradipine.
Omeprazole Omeprazole The metabolism of Sunitinib can be increased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Sunitinib can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Sunitinib can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sunitinib.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Sunitinib.
Fluvoxamine Fluvoxamine The metabolism of Sunitinib can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Sunitinib can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Sunitinib.
Losartan Losartan The metabolism of Sunitinib can be decreased when combined with Losartan.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Sunitinib.
Vinorelbine Injection Vinorelbine Injection The metabolism of Sunitinib can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Sunitinib.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Sunitinib.
Lansoprazole Lansoprazole The metabolism of Sunitinib can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Sunitinib can be increased when combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Sunitinib.
Nicardipine Nicardipine The metabolism of Sunitinib can be decreased when combined with Nicardipine.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Sunitinib.
Saquinavir Saquinavir The metabolism of Sunitinib can be decreased when combined with Saquinavir.
Metformin Metformin The risk or severity of hypoglycemia can be increased when Metformin is combined with Sunitinib.
Nisoldipine Nisoldipine The metabolism of Sunitinib can be decreased when combined with Nisoldipine.
Lamivudine Lamivudine Sunitinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole Riluzole Sunitinib may decrease the excretion rate of Riluzole which could result in a higher serum level.
Acarbose Acarbose The risk or severity of hypoglycemia can be increased when Acarbose is combined with Sunitinib.
Glimepiride Glimepiride The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Sunitinib.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sunitinib.
Indinavir Indinavir The metabolism of Sunitinib can be decreased when combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Sunitinib can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Sunitinib can be decreased when combined with Docetaxel.
Clomipramine Clomipramine The metabolism of Sunitinib can be decreased when combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Sunitinib can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Mirtazapine.
Topiramate Topiramate The metabolism of Sunitinib can be increased when combined with Topiramate.
Insulin Lispro Injection Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sunitinib.
Donepezil Donepezil Sunitinib may decrease the excretion rate of Donepezil which could result in a higher serum level.
Nelfinavir Nelfinavir The metabolism of Sunitinib can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Sunitinib.
Carvedilol Carvedilol The therapeutic efficacy of Sunitinib can be increased when used in combination with Carvedilol.
Flutamide Flutamide The metabolism of Sunitinib can be decreased when combined with Flutamide.
Selegiline Selegiline Selegiline may increase the hypoglycemic activities of Sunitinib.
Bicalutamide Bicalutamide The metabolism of Sunitinib can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of hypoglycemia can be increased when Sertraline is combined with Sunitinib.
Propafenone Propafenone The therapeutic efficacy of Sunitinib can be increased when used in combination with Propafenone.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Sunitinib.
Irbesartan Irbesartan The metabolism of Sunitinib can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin The therapeutic efficacy of Sunitinib can be increased when used in combination with Tamsulosin.
Finasteride Finasteride The metabolism of Sunitinib can be decreased when combined with Finasteride.
Quetiapine Quetiapine The metabolism of Sunitinib can be decreased when combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Sunitinib.
Paroxetine Paroxetine The metabolism of Sunitinib can be decreased when combined with Paroxetine.
Citalopram Citalopram The metabolism of Citalopram can be decreased when combined with Sunitinib.
Capecitabine Capecitabine The risk or severity of QTc prolongation can be increased when Capecitabine is combined with Sunitinib.
Efavirenz Efavirenz The metabolism of Sunitinib can be increased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Sunitinib can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The risk or severity of hypoglycemia can be increased when Pioglitazone is combined with Sunitinib.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Sunitinib.
Celecoxib Celecoxib The therapeutic efficacy of Sunitinib can be increased when used in combination with Celecoxib.
Rosiglitazone Rosiglitazone The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Sunitinib.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Sunitinib.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Sunitinib.
Balsalazide Balsalazide Balsalazide may increase the hypoglycemic activities of Sunitinib.
Nateglinide Nateglinide The metabolism of Sunitinib can be decreased when combined with Nateglinide.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sunitinib.
Rabeprazole Rabeprazole The metabolism of Sunitinib can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Sunitinib can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists